Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
1(6%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
6%
Ph phase_2
4
25%
Ph phase_4
2
13%
Ph not_applicable
4
25%
Ph phase_3
5
31%

Phase Distribution

1

Early Stage

4

Mid Stage

7

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
1(6.3%)
Phase 2Efficacy & side effects
4(25.0%)
Phase 3Large-scale testing
5(31.3%)
Phase 4Post-market surveillance
2(12.5%)
N/ANon-phased studies
4(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

16

all time

Status Distribution
Active(1)
Completed(15)

Detailed Status

Completed15
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.3%)
Phase 24 (25.0%)
Phase 35 (31.3%)
Phase 42 (12.5%)
N/A4 (25.0%)

Trials by Status

completed1594%
recruiting16%

Recent Activity

1 active trials
Showing 5 of 16
completednot_applicable

ED50 of Remimazolam for Anesthesia Induction in Frail Elderly Patients

NCT07467603
completednot_applicable

Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures

NCT07035301
completedphase_3

A Study of Remimazolam Tosilate for Sedation in the ICU

NCT06222294
completedphase_1

A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU

NCT05913336
recruitingphase_4

Effect on Early Cognition Under Sedation by Rimazole Toluenesulfonate in Old Patient Undergoing Colonoscopy

NCT05255211
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07467603Not Applicable

ED50 of Remimazolam for Anesthesia Induction in Frail Elderly Patients

Completed
NCT07035301Not Applicable

Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures

Completed
NCT06222294Phase 3

A Study of Remimazolam Tosilate for Sedation in the ICU

Completed
NCT05913336Phase 1

A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU

Completed
NCT05255211Phase 4

Effect on Early Cognition Under Sedation by Rimazole Toluenesulfonate in Old Patient Undergoing Colonoscopy

Recruiting
NCT06169995Phase 4

A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy

Completed
NCT05876793Not Applicable

Effective Dose of Remimazolam Combined With Propofol in Painless Gastroscopy

Completed
NCT05152303Phase 2

A Study of Remimazolam Tosilate for Sedation in the ICU

Completed
NCT05631028Not Applicable

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Completed
NCT04400201Phase 3

A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy

Completed
NCT05015361Phase 2

A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation

Completed
NCT03921775Phase 3

A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery

Completed
NCT03779061Phase 3

Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy

Completed
NCT03425474Phase 3

Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

Completed
NCT03003884Phase 2

A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy

Completed
NCT02406872Phase 2

A Study Comparing Remimazolam Tosilate and Propofol for Intravenous General Anaesthesia in Operations

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16